$4.30 -0.26 (-5.70%)
2/10/2012 4:00 PM

XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Featured Broker Partners


Advertisement